NPPA and cardiac hypertrophy: Sirt6.Tg mice showed reduced cardiac hypertrophy, as measured by a decreased HW/TL ratio and mRNA levels for βMHC and ANF, compared to non-transgenic wild-type controls (Figure 6A, 6B).